好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Digital Speech Markers of Lexical Dysfluency in Primary Progressive Aphasia
Aging, Dementia, and Behavioral Neurology
S42 - Perspectives on Non-Alzheimer's Dementia Diagnostics and Therapeutics (1:36 PM-1:48 PM)
004

To determine whether automated lexical dysfluency analysis can differentiate non-fluent variant primary progressive aphasia (nfvPPA) from logopenic variant PPA (lvPPA), which are often difficult to distinguish in early disease stages.

NfvPPA and lvPPA present with overlapping language impairments but distinct underlying mechanisms: nfvPPA shows motor-speech disruptions, while lvPPA involves phonological errors. Automated speech recognition (ASR) systems can aid objective speech analysis but often miss dysfluencies as they prioritize fluent transcription. We developed a forced-alignment–based approach, the Scalable Speech Dysfluency Modeling Lightweight system (SSDM-L), to capture phoneme- and word-level disruptions overlooked by conventional ASR.

Participants included 40 individuals with nfvPPA, 40 with lvPPA, and 27 healthy controls who read aloud the ‘Grandfather passage’. Eight dysfluency variables were extracted using SSDM-L, including insertions, replacements, deletions at both phoneme- and word-levels, and phoneme-level prolongations and repetitions. Group differences were assessed via ANCOVAs controlling for age, education, and disease severity (MMSE, CDR sum-of-boxes). To test clinical validation, we performed correlation analyses with the gold-standard expert Motor Speech Exam (MSE) ratings within the nfvPPA group. Classification performance was assessed by training XGBoost machine-learning models including 5-fold cross-validation.

All features distinguished PPA from controls (p<.001–.004). NfvPPA individuals made more errors than lvPPA individuals on each of the eight features (p<.001–.023). Each feature showed a moderate positive correlation with the combined MSE apraxia/dysarthria score (r = .31–.56; p<.001-.053). Together, the eight features were able to classify nfvPPA vs lvPPA at AUC=.792 [95% confidence interval: .600-.983], and adding age, education, and disease severity improved model performance to AUC=.917 [.805-1.00].

Automated phoneme- and word-level dysfluency analysis accurately distinguishes PPA variants using a brief reading task. This objective, scalable method reduces reliance on expert perceptual judgment and addresses current limitations of ASR, offering a clinically practical tool for differential diagnosis in language-based dementias.

Authors/Disclosures
Jet M. Vonk, PhD, PhD
PRESENTER
Dr. Vonk has nothing to disclose.
JIACHEN LIAN, PhD Mr. LIAN has received personal compensation for serving as an employee of Meta. Mr. LIAN has received intellectual property interests from a discovery or technology relating to health care.
Zoe Ezzes Ms. Ezzes has received research support from NIH (T32 training grant).
Lisa Wauters, PhD Dr. Wauters has a non-compensated relationship as a volunteer with National Aphasia Association that is relevant to AAN interests or activities.
Young Min Cho, MD, PhD Prof. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hanmi. The institution of Prof. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LG Chemical. Prof. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daewoong. Prof. Cho has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Daewoong.
Brittany T. Morin Mrs. Morin has nothing to disclose.
Rian L. Bogley (UCSF) Mr. Bogley has nothing to disclose.
Diana A. Rodriguez, Bachelor of Science Ms. Rodriguez has nothing to disclose.
Boon Lead Tee, MD (University of California San Francisco) The institution of Boon Lead Tee, MD has received research support from Global Brain Health Institute. The institution of Boon Lead Tee, MD has received research support from Alzheimer's Association.
Jessica Deleon, MD (University of California, San Francisco) The institution of Dr. Deleon has received research support from NIH.
Zachary Miller, MD (UCSF Memory and Aging Center) Dr. Miller has nothing to disclose.
MARIA LUISA MANDELLI, PhD Prof. MANDELLI has nothing to disclose.
Gopala K. Anumanchipalli, PhD Prof. Anumanchipalli has nothing to disclose.
Maria Luisa Gorno Tempini, MD, PhD (UCSF Memory and Aging Center) The institution of Dr. Gorno Tempini has received research support from the NIH.